top of page
CSI's official WeChat account is now LIVE!
Launching our official WeChat account marks another milestone in CSI's global growth, making it even easier for pharmaceutical, biotechnology and CRO partners across China and the Asia-Pacific region to connect with us. Follow our WeChat account to stay up to date with: • Clinical trial supply insights • Comparator sourcing expertise • Company news and updates • Industry developments • Event announcements As we continue to expand our global presence, we're excited to stre
Clinical Services International (CSI)
Jul 27
Case Study: Global Sourcing of Opdivo (Nivolumab) for an Oncology Study
Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation. Challenge There were several key
Clinical Services International (CSI)
Oct 21, 2025
News and Insights
.png){kind=logo}
bottom of page